EP0871480A4 - T cells mediating an immune response and methods of use - Google Patents

T cells mediating an immune response and methods of use

Info

Publication number
EP0871480A4
EP0871480A4 EP97912648A EP97912648A EP0871480A4 EP 0871480 A4 EP0871480 A4 EP 0871480A4 EP 97912648 A EP97912648 A EP 97912648A EP 97912648 A EP97912648 A EP 97912648A EP 0871480 A4 EP0871480 A4 EP 0871480A4
Authority
EP
European Patent Office
Prior art keywords
methods
immune response
cells mediating
mediating
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97912648A
Other languages
German (de)
French (fr)
Other versions
EP0871480A1 (en
Inventor
David Berd
Giorgio Parmiani
Andrea Anichini
Marialuisa Sensi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of EP0871480A1 publication Critical patent/EP0871480A1/en
Publication of EP0871480A4 publication Critical patent/EP0871480A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP97912648A 1996-10-04 1997-10-02 T cells mediating an immune response and methods of use Withdrawn EP0871480A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2700296P 1996-10-04 1996-10-04
PCT/US1997/015741 WO1998014206A1 (en) 1996-10-04 1997-10-02 T cells mediating an immune response and methods of use
US27002P 2008-02-07

Publications (2)

Publication Number Publication Date
EP0871480A1 EP0871480A1 (en) 1998-10-21
EP0871480A4 true EP0871480A4 (en) 2001-04-04

Family

ID=21835095

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97912648A Withdrawn EP0871480A4 (en) 1996-10-04 1997-10-02 T cells mediating an immune response and methods of use

Country Status (7)

Country Link
EP (1) EP0871480A4 (en)
AU (1) AU4976697A (en)
CA (1) CA2242590A1 (en)
IL (1) IL125747A0 (en)
NZ (1) NZ330995A (en)
PL (1) PL328790A1 (en)
WO (1) WO1998014206A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301174A (en) * 1998-04-09 2001-06-27 托马斯杰斐逊大学 Method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
EP1082134B1 (en) * 1998-05-04 2008-07-16 Thomas Jefferson University Use of haptenised tumour cells and extracts thereof
ATE341338T1 (en) 1999-03-16 2006-10-15 Univ Jefferson HAPTEN MODIFIED TUMOR CELLS AND METHOD FOR THE PRODUCTION AND USE THEREOF
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
AU2003243485A1 (en) 2002-06-10 2003-12-22 Avax Technologies Inc. Cryopreservation of haptenized tumor cells
US20070134670A1 (en) * 2003-12-12 2007-06-14 Bayer Pharmaceuticals Corporation Methods for prediction and prognosis of cancer, and monitoring cancer therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668350A1 (en) * 1994-02-16 1995-08-23 Akzo Nobel N.V. Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (en) * 1988-03-01 1989-09-14 Deutsches Krebsforsch VIRUS-MODIFIED TUMOR VACCINES FOR THE IMMUNOTHERAPY OF TUMOR METAL KEYS
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
DE69637440T2 (en) * 1995-06-07 2009-03-05 Thomas Jefferson University HAPTEN-MODIFIED TUMORCLE ILLACTRAKT AND METHOD FOR THE TREATMENT OF CANCER

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668350A1 (en) * 1994-02-16 1995-08-23 Akzo Nobel N.V. Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CAIGNARD A ET AL: "In situ demonstration of renal-cell-carcinoma-specific T-cell clones.", INTERNATIONAL JOURNAL OF CANCER, vol. 66, no. 4, 1996, pages 564 - 570, XP002159122 *
SATO T: "Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine.", CANCER IMMUNOLOGY IMMUNOTHERAPY, vol. 43, no. 3, 1996, pages 174 - 179, XP000953008 *
See also references of WO9814206A1 *
SENSI M ET AL.: "Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.", JOURNAL OF CLINICAL INVESTIGATION, vol. 99, no. 4, 15 February 1997 (1997-02-15), pages 710 - 717, XP000953042 *
SENSI M ET AL.: "Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 92, no. 12, 1 June 1995 (1995-06-01), pages 5674 - 5678, XP002143225 *
WEIDMANN E ET AL.: "Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.", CANCER RESEARCH, vol. 53, no. 20, 1993, pages 4745 - 4749, XP002150949 *

Also Published As

Publication number Publication date
EP0871480A1 (en) 1998-10-21
IL125747A0 (en) 1999-04-11
NZ330995A (en) 2000-12-22
PL328790A1 (en) 1999-02-15
AU4976697A (en) 1998-04-24
CA2242590A1 (en) 1998-04-09
WO1998014206A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
EP0921816A4 (en) Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
PL334242A1 (en) Fusion-type protein ob - compositions and methods
EP1021185A4 (en) Didhydropyrimidines and uses thereof
IL120079A0 (en) An ultrasound system and methods utilizing same
PL329949A1 (en) Method of obtaining copolymers and mixtures containing them
EP0894807A4 (en) GPIb-LIPID COMPLEX AND USES THEREOF
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
PL333304A1 (en) Techniques and methods of tuberculosis diagnosis
IL116984A (en) Multiple FIFO array and method of construction thereof
EP0554215A3 (en) Diacrylates and dimethacrylates
AU5044898A (en) Glycolipid mimics and methods of use thereof
EP0947581A4 (en) Culture medium and use of the same
HUP0000316A2 (en) Exodus chemokine materials and methods
AU7378498A (en) Hybrid ribozymes and methods of use
EP0960201A4 (en) Mammalian ribonuclease inhibitors and use thereof
IL125747A0 (en) T cells mediating an immune response and methods of use
GB9724377D0 (en) Accumulator circuit and method of use thereof
GB2329812B (en) User interface systems and methods
HUP9800146A3 (en) Thalidomide-derivatives and use of them
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB2329749B (en) Digital recording systems and methods
PL328334A1 (en) Preparation and application thereof
IL124430A0 (en) An envelope and an envelope construction
GB9523574D0 (en) Method of providing an easy open pack, and pack made thereby
GB9623539D0 (en) Enzymes and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 980714;LT PAYMENT 980714;LV PAYMENT 980714;RO PAYMENT 980714;SI PAYMENT 980714

17P Request for examination filed

Effective date: 19981001

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 5/06 A, 7G 01N 33/574 B, 7C 07K 14/705 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010215

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20010615